With the fourth UN High-Level Meeting on Noncommunicable Diseases (NCDs) and Mental Health just three months away, momentum is building around how countries can strengthen sustainable and people-centered financing for NCDs.

During the World Health Assembly in May, Access Accelerated—alongside PATH, the Coalition for Access to NCD Medicines & Products, and Novo Nordisk—convened a high-level side event, From Promise to Practice: Financing Sustainable NCD Responses in a Changing World, to examine practical solutions and explore the path forward.

The event opened with a keynote address from H.E. Budi Gunadi Sadikin, Minister of Health of Indonesia, who shared how Indonesia is pairing ambition with implementation—mobilizing national efforts to screen all 280 million citizens for NCDs by 2029.

Representatives from Ghana and Kenya joined Indonesia in sharing national experiences in mobilizing domestic resources and improving the efficiency of NCD investments.

MedAccess introduced a groundbreaking pay-per-use financing model—the first of its kind in Africa—that connects governments with the private sector to expand access to life-saving radiotherapy. The model demonstrates how innovative, risk-sharing finance can make high-cost technologies more accessible and sustainable in lower-resource settings.

The Financing Accelerator Network for NCDs (FAN), PATH, and the Coalition4NCDs provided analysis of the broader financing landscape and offered practical recommendations to support scale and long-term sustainability.

The discussion underscored a shared challenge: how to secure sustainable investment in NCD responses amid rising demand and constrained fiscal space. Yet it also revealed promising models that are already working—and ready to be adapted and scaled.

We’ve captured the key insights and outcomes in a full event report—now available below:

• Read the full report
• Watch the event recording

As the global health community prepares for the 2025 High-Level Meeting, these insights offer a timely resource to inform policy, align investment, and drive more equitable NCD responses.